Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.9% |
| 2 | Healthcare | 14.3% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Communication Services | 10.98% |
| 5 | Industrials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
International Bancshares
IBOC
$4.53B
| $5.71M | ﹤0.01% |
122,900
+1,000
| +0.8% | +$43.9K |
|
|
ARNC
1377
DELISTED
Arconic Corporation
ARNC
| $5.7M | ﹤0.01% |
224,400
+2,000
| +0.9% | +$53.7K |
|
1378
Axos Financial
AX
$5.73B
| $5.69M | ﹤0.01% |
121,100
| – | – |
|
|
NVMI
1379
Nova
NVMI
$13.1B
| $5.68M | ﹤0.01% |
64,740
+821
| +1% | +$66.3K |
|
|
CCXI
1380
DELISTED
ChemoCentryx, Inc.
CCXI
| $5.67M | ﹤0.01% |
110,700
+1,700
| +2% | +$102K |
|
1381
Hamilton Lane
HLNE
$5.86B
| $5.65M | ﹤0.01% |
63,800
+4,500
| +8% | +$380K |
|
1382
Winnebago Industries
WGO
$909M
| $5.62M | ﹤0.01% |
73,300
+700
| +1% | +$50.5K |
|
1383
First Bancorp
FBP
$4.51B
| $5.61M | ﹤0.01% |
498,600
+4,200
| +0.8% | +$44.1K |
|
1384
Ligand Pharmaceuticals
LGND
$5.78B
| $5.61M | ﹤0.01% |
58,990
+641
| +1% | +$60.6K |
|
|
ITCI
1385
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.59M | ﹤0.01% |
164,800
+3,700
| +2% | +$128K |
|
|
RCM
1386
DELISTED
R1 RCM Inc. Common Stock
RCM
| $5.59M | ﹤0.01% |
226,600
+4,500
| +2% | +$119K |
|
1387
Forward Air
FWRD
$669M
| $5.59M | ﹤0.01% |
62,900
-500
| -0.8% | -$41.9K |
|
|
RETA
1388
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $5.58M | ﹤0.01% |
56,000
+1,100
| +2% | +$128K |
|
1389
Moog Inc Class A
MOG.A
$13.7B
| $5.58M | ﹤0.01% |
67,100
-900
| -1% | -$72K |
|
|
MIME
1390
DELISTED
Mimecast Limited
MIME
| $5.57M | ﹤0.01% |
138,600
+3,000
| +2% | +$132K |
|
|
APLS
1391
DELISTED
Apellis Pharmaceuticals
APLS
| $5.57M | ﹤0.01% |
129,800
+1,600
| +1% | +$75.7K |
|
1392
Viasat
VSAT
$11.4B
| $5.56M | ﹤0.01% |
115,724
+1,300
| +1% | +$62.9K |
|
1393
MillerKnoll
MLKN
$1.61B
| $5.54M | ﹤0.01% |
134,600
+1,400
| +1% | +$53.6K |
|
1394
WesBanco
WSBC
$4.1B
| $5.54M | ﹤0.01% |
153,545
+1,600
| +1% | +$52.6K |
|
1395
Gentherm
THRM
$1.31B
| $5.54M | ﹤0.01% |
74,700
+800
| +1% | +$56.8K |
|
|
KC
1396
Kingsoft Cloud Holdings
KC
$3.51B
| $5.53M | ﹤0.01% |
140,716
+14,500
| +11% | +$770K |
|
1397
John Wiley & Sons Class A
WLY
$2.63B
| $5.52M | ﹤0.01% |
101,900
+800
| +0.8% | +$40.7K |
|
1398
Methanex
MEOH
$4.25B
| $5.5M | ﹤0.01% |
149,000
+1,800
| +1% | +$70.3K |
|
1399
MaxLinear
MXL
$7.01B
| $5.49M | ﹤0.01% |
160,973
+3,900
| +2% | +$139K |
|
1400
Murphy Oil
MUR
$4.94B
| $5.47M | ﹤0.01% |
333,400
+2,700
| +0.8% | +$42.2K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.